SAVACASSAVA SCIENCES INC

Nasdaq cassavasciences.com


$ 20.75 $ 0.25 (1.22 %)    

Tuesday, 23-Apr-2024 13:40:17 EDT
QQQ $ 425.00 $ 4.94 (1.18 %)
DIA $ 385.17 $ 2.80 (0.73 %)
SPY $ 505.54 $ 3.68 (0.73 %)
TLT $ 89.25 $ 0.53 (0.6 %)
GLD $ 215.31 $ 1.85 (0.87 %)
$ 20.5
$ 20.50
$ 20.69 x 200
$ 21.29 x 1,000
$ 20.50 - $ 21.09
$ 12.32 - $ 32.10
767,487
na
886.12M
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-01-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-07-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-28-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 04-29-2021 03-31-2021 10-Q
13 03-23-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-12-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 03-26-2020 12-31-2019 10-K
18 10-29-2019 09-30-2019 10-Q
19 08-12-2019 06-30-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 03-29-2019 12-31-2018 10-K
22 10-30-2018 09-30-2018 10-Q
23 07-26-2018 06-30-2018 10-Q
24 05-09-2018 03-31-2018 10-Q
25 02-06-2018 12-31-2017 10-K
26 11-01-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 04-26-2017 03-31-2017 10-Q
29 03-07-2017 12-31-2016 10-K
30 10-26-2016 09-30-2016 10-Q
31 07-19-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
33 03-03-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 07-23-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 02-18-2015 12-31-2014 10-K
38 11-05-2014 09-30-2014 10-Q
39 08-06-2014 06-30-2014 10-Q
40 05-07-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

 cassava-sciences-completes-interim-safety-review-of-oral-simufilam-on-going-phase-3-trials

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufila...

 alzheimers-drug-trial-results-questioned-after-damning-fda-inspection-report

The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following ...

 boeing-oracle-meta-platforms-cassava-sciences-tesla-why-these-5-stocks-are-on-investors-radars-today

On Monday, the U.S. stock market presented a mixed performance. The Dow Jones index managed to turn higher, trading up by 0.12%...

 hc-wainwright--co-reiterates-buy-on-cassava-sciences-maintains-124-price-target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) with a Buy and maintains $124 pr...

 cassava-sciences-q4-eps-050-beats-052-estimate

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0....

 why-alzheimers-drug-developer-cassava-sciences-stock-is-trending

The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam...

 cassava-sciences-reports-top-line-results-of-two-year-clinical-safety-study-of-simufilam-investigational-oral-drug-for-treatment-of-alzheimers-disease

ADAS-Cog Scores Were Stable in a Group of Patients with Mild Alzheimer's Who Received Drug Candidate Simufilam Continuously...

 cassava-sciences-announced-that-it-will-distribute-warrants-to-purchase-shares-of-common-stock-to-its-shareholders-on-jan-3-2024-with-each-shareholder-receiving-four-warrants-for-every-ten-shares-of-common-stock-they-hold

https://www.sec.gov/ix?doc=/Archives/edgar/data/1069530/000149315224000209/form8-k.htm

 why-carmax-shares-are-trading-higher-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

 paychex-reports-downbeat-sales-joins-blackberry-and-other-big-stocks-moving-lower-on-thursday

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday.

 blue-bird-posts-upbeat-results-joins-oil-dri-corporation-of-america-eagle-bulk-shipping-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Tuesday.

 whats-going-on-with-cassava-sciences-stock

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher Monday on continued upward momentum. The stock has gained more ...

 cassava-sciences-q3-eps-061-beats-077-estimate

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0....

 cassava-sciences-completes-enrollment-for-pivotal-phase-3-program-of-simufilam-in-alzheimers-disease

1,929 patients randomized in a pair of Phase 3 trials to evaluate oral simufilam in Alzheimer's disease dementia.Top-line r...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION